Count | |
| 1 | |
| 3 | |
| 1 | |
| 21 | |
| 8 | |
| 1 | |
| 5 | |
| 20 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Blood Component Transfusion/adverse effects/*methods/standards | 1 |
| 15 | |
| 1 | |
| 22 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Serum Amyloid P-Component/analysis/*isolation & purification | 1 |
| 1 | |
Secretory Component/*analysis/*immunology/isolation & purification | 1 |
| 1 | |
Serum Amyloid P-Component/analysis/*biosynthesis/isolation & purification | 1 |
| 7 | |
| 3 | |
| 4 | |
| 2 | |
| 10 | |
| 1 | |
| 47 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 3 | |
| 13 | |
| 29 | |
| 11 | |
| 9 | |
| 16 | |
| 3 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 6 | |
| 1 | |
| 4 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 17 | |
| 1 | |
| 2 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 5 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |